EW Revenue Flow Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.
2026-06-30: Revenue $1.74B ; Cost of revenue $392.40M ; Research and development $278.90M ; Selling, general and administrative $561.20M . 2026-03-31: Revenue $1.65B ; Cost of revenue $362.60M ; Research and development $263.30M ; Selling, general and administrative $522.20M . 2025-12-31: Revenue $1.57B* ; Cost of revenue $343.00M* ; Research and development $267.70M* ; Selling, general and administrative $602.90M* . 2025-09-30: Revenue $1.55B ; Cost of revenue $345.20M ; Research and development $280.70M ; Selling, general and administrative $514.60M . Consolidation item Separate filed amounts; connecting flows are not established. Components and totals may overlap.
EW revenue flow Filed amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow. Operating Segments $1.74B Revenue $1.74B Cost of revenue $392.40M Gross profit $1.35B Operating income $513.20M Other income, net $16.60M Research & development $278.90M Selling, general & administrative $561.20M Pre-tax income $519.80M Income tax $278.40M
Product or service Separate filed amounts; connecting flows are not established. Components and totals may overlap.
EW revenue flow Filed amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow. Surgical $284.10M Transcatheter Aortic Valve Replacement $1.26B Transcatheter Mitral And Tricuspid Therapies $198.60M Revenue $1.74B Cost of revenue $392.40M Gross profit $1.35B Operating income $513.20M Other income, net $16.60M Research & development $278.90M Selling, general & administrative $561.20M Pre-tax income $519.80M Income tax $278.40M
Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.
Historical revenue and expense breakdown Revenue and expense 3 month Period end Revenue Cost of revenue Research and development Selling, general and administrative Income tax Net income 2026-06-30 $1.74B $392.40M $278.90M $561.20M $278.40M $241.90M 2026-03-31 $1.65B $362.60M $263.30M $522.20M $78.30M $380.70M 2025-12-31 $1.57B* $343.00M* $267.70M* $602.90M* $26.20M* $91.20M* 2025-09-30 $1.55B $345.20M $280.70M $514.60M $56.10M $291.10M 2025-06-30 $1.53B $344.40M $276.20M $502.00M $64.30M $333.20M 2025-03-31 $1.41B $301.60M $254.60M $465.70M $70.30M $358.00M 2024-12-31 $1.39B (m) (m) (m) (m) $385.60M 2024-09-30 $1.35B $262.90M $253.40M $421.40M $40.70M $3.07B 2024-06-30 $1.37B $275.50M $271.80M $447.50M $20.00M $366.30M 2024-03-31 $1.33B $286.90M $256.70M $428.40M $46.30M $351.90M 2023-12-31 $1.27B (m) (m) (m) (m) $369.90M 2023-09-30 $1.24B $250.60M $242.80M $381.90M $52.70M $384.90M 2023-06-30 $1.28B $256.90M $243.70M $410.40M $20.90M $307.10M 2023-03-31 $1.22B $329.50M $261.20M $436.30M $58.10M $340.50M 2022-09-30 $1.32B $253.80M $233.60M $377.30M $63.80M $343.50M 2022-06-30 $1.37B $269.40M $250.80M $409.00M $58.30M $406.40M 2022-03-31 $1.34B $299.30M $228.60M $370.30M $62.50M (m) 2021-09-30 $1.31B $311.70M $238.00M $364.40M $50.80M (m) 2021-06-30 $1.38B $334.30M $225.30M $374.50M $56.00M (m) 2021-03-31 $1.22B $293.40M $207.00M $330.80M $51.10M (m) 2020-12-31 $1.19B (m) (m) (m) (m) (m) 2020-09-30 $1.14B $281.00M $195.50M $307.20M $39.10M (m) 2020-06-30 $925.00M $238.20M $182.10M $274.90M -$46.30M (m) 2020-03-31 $1.13B $265.10M $187.40M $307.80M $53.90M (m) 2019-12-31 $1.17B (m) (m) (m) (m) (m) 2019-09-30 $1.09B $292.40M $195.50M $306.20M $27.00M (m) 2019-06-30 $1.09B $304.00M $191.90M $308.50M $29.00M (m) 2019-03-31 $993.00M $231.80M $171.40M $280.30M $28.30M (m) 2018-12-31 $977.70M (m) (m) (m) (m) (m) 2018-09-30 $906.60M $224.90M $161.80M $269.50M $22.80M (m) 2018-06-30 $943.70M $246.20M $154.10M $274.90M -$31.70M (m) 2018-03-31 $894.80M $233.60M $143.20M $256.00M $56.90M (m) 2017-12-31 $888.50M (m) (m) (m) (m) (m) 2017-09-30 $821.50M $213.30M $142.90M $244.60M $41.70M (m) 2017-06-30 $841.80M $211.10M $134.40M $243.80M $19.50M (m) 2017-03-31 $883.50M $215.60M $128.70M $229.60M $63.40M (m) 2016-12-31 $767.70M (m) (m) (m) (m) (m) 2016-09-30 $739.40M $201.40M $113.00M $229.60M $43.80M (m) 2016-06-30 $759.30M $202.50M $112.50M $228.80M $42.40M (m) 2016-03-31 $697.30M $180.30M $101.80M $212.70M $40.30M (m) 2015-12-31 $671.10M (m) (m) (m) (m) (m) 2015-09-30 $615.50M $146.70M $101.00M $212.00M $32.60M (m) 2015-06-30 $616.80M $158.60M $97.50M $213.90M $29.50M (m) 2015-03-31 $590.30M $136.00M $86.40M $202.50M $39.10M (m) 2014-12-31 $618.00M (m) (m) (m) (m) (m) 2014-09-30 $607.40M $168.10M $87.60M $222.20M $26.00M (m) 2014-06-30 $575.10M $151.20M $89.10M $215.50M $266.20M (m) 2014-03-31 $522.40M $145.90M $85.80M $197.20M $17.00M (m) 2013-12-31 $536.00M (m) (m) (m) (m) (m) 2013-09-30 $495.60M $128.20M $84.10M $177.80M $23.00M (m) 2013-06-30 $517.20M $123.60M $80.50M $186.60M $27.20M (m) 2013-03-31 $496.70M $121.00M $79.80M $182.40M $46.70M (m) 2012-12-31 $510.50M (m) (m) (m) (m) (m) 2012-09-30 $447.90M $111.70M $73.80M $167.80M $24.20M (m) 2012-06-30 $482.00M $129.80M $74.00M $182.40M $22.10M (m) 2012-03-31 $459.20M $127.30M $68.60M $177.20M $20.50M (m) 2011-12-31 $430.20M (m) (m) (m) (m) (m) 2011-09-30 $412.70M $125.60M $61.70M $165.50M $6.00M (m) 2011-06-30 $431.20M $127.80M $64.90M $163.20M $14.70M (m) 2011-03-31 $404.50M $116.80M $59.00M $150.30M $20.70M (m) 2010-12-31 $392.40M (m) (m) (m) (m) (m) 2010-09-30 $348.90M $95.80M $52.70M $133.00M $18.20M (m) 2010-06-30 $365.20M $100.40M $50.60M $140.60M $8.90M (m) 2010-03-31 $340.50M $98.60M $45.20M $134.00M $17.80M (m) 2009-12-31 $346.70M (m) (m) (m) (m) (m) 2009-09-30 $325.70M $98.50M $44.70M $126.10M $20.70M (m) 2009-06-30 $335.50M $101.90M $42.60M $128.50M $15.30M (m) 2009-03-31 $313.50M (m) (m) (m) (m) (m)
Revenue and expense 6 month Period end Revenue Cost of revenue Research and development Selling, general and administrative Income tax Net income 2026-06-30 $3.39B $755.00M $542.20M $1.08B $356.70M $622.60M 2025-06-30 $2.94B $646.00M $530.80M $967.70M $134.60M $691.20M 2024-06-30 $2.70B $562.40M $528.50M $875.90M $66.30M $718.20M 2023-06-30 $2.53B $495.90M $478.50M $792.40M $66.20M $647.60M 2022-06-30 $2.72B $568.70M $479.40M $779.30M $120.80M $780.00M 2021-06-30 $2.59B $627.70M $432.30M $705.30M $107.10M (m) 2020-06-30 $2.05B $503.30M $369.50M $582.70M $7.60M (m) 2019-06-30 $2.08B $535.80M $363.30M $588.80M $57.30M (m) 2018-06-30 $1.84B $479.80M $297.30M $530.90M $25.20M (m) 2017-06-30 $1.73B $426.70M $263.10M $473.40M $82.90M (m) 2016-06-30 $1.46B $382.80M $214.30M $441.50M $82.70M (m) 2015-06-30 $1.21B $294.60M $183.90M $416.40M $68.60M (m) 2014-06-30 $1.10B $297.10M $174.90M $412.70M $283.20M (m) 2013-06-30 $1.01B $244.60M $160.30M $369.00M $73.90M (m) 2012-06-30 $941.20M $257.10M $142.60M $359.60M $42.60M (m) 2011-06-30 $835.70M $244.60M $123.90M $313.50M $35.40M (m) 2010-06-30 $705.70M $199.00M $95.80M $274.60M $26.70M (m) 2009-06-30 $649.00M $198.90M $82.50M $250.40M $39.80M (m)
Revenue and expense 9 month Period end Revenue Cost of revenue Research and development Selling, general and administrative Income tax Net income 2025-09-30 $4.50B $991.20M $811.50M $1.48B $190.70M $982.30M 2024-09-30 $4.05B $825.30M $781.90M $1.30B $107.00M $3.79B 2023-09-30 $3.74B $727.40M $720.80M $1.17B $118.30M $1.03B 2022-09-30 $4.03B $822.50M $713.00M $1.16B $184.60M $1.12B 2021-09-30 $3.90B $939.40M $670.30M $1.07B $157.90M (m) 2020-09-30 $3.19B $784.30M $565.00M $889.90M $46.70M (m) 2019-09-30 $3.17B $828.20M $558.80M $895.00M $84.30M (m) 2018-09-30 $2.75B $704.70M $459.10M $800.40M $48.00M (m) 2017-09-30 $2.55B $640.00M $406.00M $718.00M $124.60M (m) 2016-09-30 $2.20B $584.20M $327.30M $671.10M $126.50M (m) 2015-09-30 $1.82B $441.30M $284.90M $628.40M $101.20M (m) 2014-09-30 $1.70B $465.20M $262.50M $634.90M $309.20M (m) 2013-09-30 $1.51B $372.80M $244.40M $546.80M $96.90M (m) 2012-09-30 $1.39B $368.80M $216.40M $527.40M $66.80M (m) 2011-09-30 $1.25B $370.20M $185.60M $479.00M $41.40M (m) 2010-09-30 $1.05B $294.80M $148.50M $407.60M $44.90M (m) 2009-09-30 $974.70M $297.40M $127.20M $376.50M $60.50M (m)
Revenue and expense 12 month Period end Revenue Cost of revenue Research and development Selling, general and administrative Income tax Net income 2025-12-31 $6.07B $1.33B $1.08B $2.09B $216.90M $1.07B 2024-12-31 $5.44B $1.12B $1.05B $1.79B $152.10M $4.17B 2023-12-31 $5.01B $978.40M $962.90M $1.58B $152.40M $1.40B 2022-12-31 $4.46B $723.70M $843.60M $1.36B $195.50M $1.52B 2021-12-31 $5.23B $1.25B $903.10M $1.49B $198.90M $1.50B 2020-12-31 $4.39B $1.08B $760.70M $1.23B $93.30M (m) 2019-12-31 $4.35B $1.11B $752.70M $1.24B $119.60M (m) 2018-12-31 $3.72B $939.40M $622.20M $1.09B $39.20M (m) 2017-12-31 $3.44B $875.30M $552.60M $990.80M $451.30M (m) 2016-12-31 $2.96B $797.40M $442.20M $904.70M $168.40M (m) 2015-12-31 $2.49B $617.20M $382.90M $850.70M $127.50M (m) 2014-12-31 $2.32B $625.60M $346.50M $858.00M $332.90M (m) 2013-12-31 $2.05B $516.60M $323.00M $733.40M $122.10M (m) 2012-12-31 $1.90B $491.00M $291.30M $697.40M $96.70M (m) 2011-12-31 $1.68B $489.80M $246.30M $642.40M $46.90M (m) 2010-12-31 $1.45B $408.30M $204.40M $550.00M $50.20M (m) 2009-12-31 $1.32B $399.10M $175.50M $508.80M $75.30M (m) 2008-12-31 $1.24B $419.60M $139.20M $480.60M $35.50M (m)